Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enhancing the safety of CAR-T cell therapy: Synthetic genetic switch for spatiotemporal control
Li Lu, Mingqi Xie, Bo Yang, et al.
Science Advances (2024) Vol. 10, Iss. 8
Open Access | Times Cited: 20

Showing 20 citing articles:

A self-activated and protective module enhances the preclinical performance of allogeneic anti-CD70 CAR-T cells
Zhao Zhang, Lian‐Feng Zhao, Tinghui Huang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Tethered IL15-IL15Rα augments antitumor activity of CD19 CAR-T cells but displays long-term toxicity in an immunocompetent lymphoma mouse model
Inés Sánchez-Moreno, Aritz Lasarte-Cía, Celia Martín-Otal, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 7, pp. e008572-e008572
Open Access | Times Cited: 6
Biomineralization strategy: from material manufacturing to biological regulation
Kexin Qin, Zitong Zheng, Jie Wang, et al.
Giant (2024) Vol. 19, pp. 100317-100317
Open Access | Times Cited: 5
Synthetic Gene Circuits as a Promising Approach in Cancer Immunotherapy
Bhanuprakash Ananthakumar, Nagashri Nanjundeshwara, Archana Lakshmaiah, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 391-418
Closed Access | Times Cited: 5
Anti-CD5 CAR-T cells with a tEGFR safety switch exhibit potent toxicity control
Haolong Lin, Jiali Cheng, Li Zhu, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Designer mammalian living materials through genetic engineering
Mariana Gameiro, J. Almeida-Pinto, Beatriz S. Moura, et al.
Bioactive Materials (2025) Vol. 48, pp. 135-148
Closed Access
Is there a place for engineered immune cell therapies in autoimmune diseases?
Luca Perico, Federica Casiraghi, Ariela Benigni, et al.
Trends in Molecular Medicine (2025)
Closed Access
Immune Effector Cell-associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS)
Jerry C. Lee, W. Thomas Johnson, Melissa Hines, et al.
Hematology/Oncology Clinics of North America (2025)
Open Access
Diverse potential of chimeric antigen receptor‐engineered cell therapy: Beyond cancer
Lvying Wu, Lingfeng Zhu, Jin Chen
Clinical and Translational Medicine (2025) Vol. 15, Iss. 4
Open Access
Fully equipped CARs to address tumor heterogeneity, enhance safety, and improve the functionality of cellular immunotherapies
Antonio Maria Alviano, Marta Biondi, Erica Grassenis, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Genetic circuits in synthetic biology: broadening the toolbox of regulatory devices
Marik M. Müller, Katja M. Arndt, Stefan A. Hoffmann
Frontiers in Synthetic Biology (2025) Vol. 3
Open Access
Leukemia Cell Hitchhiking Hypoxia Responsive Nanogel for Improved Immunotherapy of Acute Myeloid Leukemia
Haoting Chen, Dongyao Wang, Yuying Yao, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 3
The role of CD4+ CAR T cells in cancer immunotherapy
Camilla Bove, John Maher, Maya Glover
Translational Cancer Research (2024) Vol. 13, Iss. 5, pp. 2580-2586
Open Access | Times Cited: 1
Small molecule-regulated switches to provide functional control of CAR T cells within the patient
Charlotte U. Zajc, Elise Sylvander, Manfred Lehner, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 6, pp. 425-432
Open Access | Times Cited: 1
Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide
Clifton C. Mo, Edward Richardson, Eleonora Calabretta, et al.
Blood Reviews (2024) Vol. 66, pp. 101218-101218
Open Access | Times Cited: 1
From promise to practice: CAR T and Treg cell therapies in autoimmunity and other immune-mediated diseases
Yannick Bulliard, Robert A. Freeborn, Molly Javier Uyeda, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Synthetic Biology in T-cell Engineering Research
Irmak Yılmazer
Next frontier. (2024) Vol. 8, Iss. 1, pp. 95-95
Closed Access
Immunotherapy-Related Neurotoxicity in the Central Nervous System of Children with Cancer
Jiasen He, Jeremy Connors, Andrew Meador, et al.
Neuro-Oncology (2024)
Closed Access
Anti-HIV-1 HSPC-based gene therapy with safety kill switch to defend against and attack HIV-1 infection
Qi Guo, Keval Parikh, Jian Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Ultrasound‐Enabled Sonogenetics: Pioneering Advances in Cancer Theranostics
Beibei Zhang, Lianfeng Mo, Rong Huang, et al.
Advanced Functional Materials (2024)
Closed Access
Page 1

Scroll to top